First Header Logo Second Header Logo

Rita Pichardo

Concepts (157)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hidradenitis Suppurativa
4
2020
9
2.380
Why?
Methotrexate
2
2020
70
1.210
Why?
Dermatologic Agents
2
2020
233
0.950
Why?
Severity of Illness Index
4
2020
851
0.770
Why?
Skin Neoplasms
7
2007
220
0.770
Why?
Lichen Planus
2
2020
10
0.750
Why?
Lichen Sclerosus et Atrophicus
1
2020
10
0.630
Why?
Anti-Inflammatory Agents
2
2019
99
0.620
Why?
Vulvar Diseases
1
2020
5
0.620
Why?
Fibromyalgia
1
2020
12
0.620
Why?
Crohn Disease
1
2019
33
0.590
Why?
Quality of Life
2
2019
971
0.590
Why?
Pemphigoid Gestationis
1
2018
3
0.550
Why?
Pruritus Vulvae
1
2018
1
0.550
Why?
Vulvitis
1
2018
1
0.550
Why?
Adult
12
2020
9263
0.450
Why?
Female
20
2020
19954
0.450
Why?
Humans
28
2020
32284
0.440
Why?
Opportunistic Infections
2
2002
19
0.370
Why?
Melanosis
1
2009
14
0.290
Why?
Dermatitis, Atopic
2
2018
103
0.290
Why?
Dermis
3
2002
17
0.280
Why?
Retrospective Studies
4
2020
3612
0.270
Why?
Cryoglobulinemia
1
2008
6
0.270
Why?
Skin Ulcer
1
2008
12
0.270
Why?
Pyoderma Gangrenosum
1
2008
12
0.270
Why?
Eosinophilia
1
2007
11
0.260
Why?
Cellulitis
1
2007
12
0.260
Why?
Transients and Migrants
1
2009
197
0.250
Why?
Middle Aged
10
2020
11843
0.230
Why?
Diagnosis, Differential
6
2008
502
0.220
Why?
Male
10
2020
19434
0.210
Why?
Neurodermatitis
2
2018
3
0.210
Why?
Hispanic Americans
1
2009
772
0.200
Why?
Drug Therapy, Combination
2
2019
293
0.200
Why?
Actinomycetales
1
2002
2
0.190
Why?
Angiomatosis
1
2002
2
0.190
Why?
Lip Neoplasms
1
2002
2
0.190
Why?
Syphilis, Cutaneous
1
2002
2
0.190
Why?
Skin Diseases, Papulosquamous
1
2002
2
0.190
Why?
Leukemia, Lymphoid
1
2002
4
0.190
Why?
Fusarium
1
2002
2
0.190
Why?
Fibrosarcoma
1
2002
3
0.190
Why?
Corynebacterium Infections
1
2002
3
0.190
Why?
Lymphangioma
1
2002
7
0.190
Why?
Dermatomycoses
1
2002
7
0.190
Why?
Panniculitis, Lupus Erythematosus
1
2002
6
0.190
Why?
Nevus, Epithelioid and Spindle Cell
1
2002
4
0.190
Why?
Nevus, Pigmented
1
2002
6
0.190
Why?
Granuloma
1
2002
14
0.190
Why?
Sarcoma, Kaposi
1
2002
9
0.190
Why?
Mycosis Fungoides
1
2002
12
0.190
Why?
Salivary Gland Neoplasms
1
2002
13
0.190
Why?
Prevalence
2
2020
960
0.190
Why?
Scalp
1
2002
35
0.180
Why?
Adenoma
1
2002
35
0.180
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2002
42
0.180
Why?
Head and Neck Neoplasms
1
2002
137
0.170
Why?
Skin Diseases
1
2002
135
0.160
Why?
Aged
6
2020
10257
0.160
Why?
Genitalia
1
2020
9
0.160
Why?
Melanoma
3
2007
166
0.150
Why?
Observer Variation
1
2019
96
0.140
Why?
Health Surveys
1
2019
175
0.140
Why?
Vulvar Lichen Sclerosus
1
2018
1
0.140
Why?
Vulvar Neoplasms
1
2018
6
0.140
Why?
Dermatitis, Contact
1
2018
8
0.140
Why?
Aged, 80 and over
3
2020
3896
0.140
Why?
Photochemotherapy
1
2018
14
0.140
Why?
Young Adult
2
2018
2652
0.130
Why?
Case-Control Studies
1
2019
858
0.130
Why?
Reproducibility of Results
1
2019
755
0.120
Why?
Postmenopause
1
2018
424
0.120
Why?
Pregnancy
1
2018
963
0.110
Why?
Neurilemmoma
2
2005
17
0.100
Why?
Skin
2
2008
214
0.100
Why?
Psoriasis
1
2018
355
0.100
Why?
Immunocompromised Host
2
2002
53
0.090
Why?
Treatment Outcome
1
2020
3410
0.090
Why?
Adolescent
4
2009
3521
0.090
Why?
Mastocytosis, Cutaneous
1
2008
3
0.070
Why?
Probability
1
2009
154
0.070
Why?
Age Distribution
1
2009
194
0.070
Why?
Amyloidosis
1
2008
16
0.070
Why?
Analysis of Variance
1
2009
470
0.070
Why?
Cetirizine
1
2007
1
0.060
Why?
Anti-Allergic Agents
1
2007
6
0.060
Why?
Blister
1
2007
7
0.060
Why?
Prednisone
1
2007
69
0.060
Why?
Pruritus
1
2007
46
0.060
Why?
Administration, Oral
1
2007
201
0.060
Why?
Longitudinal Studies
1
2009
760
0.060
Why?
Sentinel Lymph Node Biopsy
1
2007
71
0.060
Why?
Recurrence
1
2007
287
0.060
Why?
Lymph Nodes
1
2007
114
0.060
Why?
Microtubule-Associated Proteins
1
2005
32
0.060
Why?
North Carolina
1
2009
1299
0.050
Why?
Soft Tissue Neoplasms
1
2005
37
0.050
Why?
Neoplasm Invasiveness
1
2005
180
0.050
Why?
Leiomyoma
1
2004
15
0.050
Why?
Cross-Sectional Studies
1
2009
1485
0.050
Why?
Uterine Neoplasms
1
2004
26
0.050
Why?
Infant
2
2008
1024
0.050
Why?
Parakeratosis
1
2003
3
0.050
Why?
Axilla
1
2003
18
0.050
Why?
Leprosy
1
2002
2
0.050
Why?
Neurofibroma
1
2002
2
0.050
Why?
Nevus, Blue
1
2002
3
0.050
Why?
Leishmaniasis
1
2002
3
0.050
Why?
Antibodies, Anticardiolipin
1
2002
5
0.050
Why?
Germinal Center
1
2002
6
0.050
Why?
Giant Cells
1
2002
4
0.050
Why?
Histiocytoma, Benign Fibrous
1
2002
6
0.050
Why?
Clone Cells
1
2002
35
0.050
Why?
Salivary Glands, Minor
1
2002
10
0.050
Why?
Cell Proliferation
1
2005
599
0.050
Why?
Mycoses
1
2002
20
0.050
Why?
Sarcoidosis
1
2002
33
0.050
Why?
HIV-1
1
2002
46
0.050
Why?
Lymphocytes
1
2002
56
0.050
Why?
Breast
1
2002
63
0.050
Why?
Upper Extremity
1
2002
68
0.040
Why?
Cholesterol
1
2002
258
0.040
Why?
Immunohistochemistry
2
2005
544
0.020
Why?
Silver Sulfadiazine
1
2008
4
0.020
Why?
Mast Cells
1
2008
13
0.020
Why?
Fluocinonide
1
2008
11
0.020
Why?
Proto-Oncogene Proteins c-kit
1
2008
24
0.020
Why?
Anti-Infective Agents, Local
1
2008
20
0.020
Why?
Ubiquitin Thiolesterase
1
2008
7
0.020
Why?
Epidermis
1
2008
29
0.020
Why?
Nerve Fibers
1
2008
38
0.020
Why?
Glucocorticoids
1
2008
146
0.020
Why?
Frozen Sections
1
2007
19
0.020
Why?
Cytological Techniques
1
2007
16
0.020
Why?
Intraoperative Care
1
2007
52
0.020
Why?
Lymph Node Excision
1
2007
94
0.020
Why?
Lymphatic Metastasis
1
2007
169
0.020
Why?
Disease-Free Survival
1
2007
322
0.010
Why?
Sensitivity and Specificity
1
2007
555
0.010
Why?
Neoplasm Staging
1
2007
458
0.010
Why?
Mitosis
1
2005
17
0.010
Why?
S100 Proteins
1
2005
20
0.010
Why?
Neuroblastoma
1
2005
31
0.010
Why?
Flow Cytometry
1
2005
184
0.010
Why?
Survival Rate
1
2007
892
0.010
Why?
Blotting, Western
1
2005
297
0.010
Why?
Survival Analysis
1
2005
478
0.010
Why?
Apoptosis
1
2005
367
0.010
Why?
Triamcinolone
1
2003
12
0.010
Why?
Cell Line, Tumor
1
2005
726
0.010
Why?
Cell Differentiation
1
2005
452
0.010
Why?
Administration, Topical
1
2003
141
0.010
Why?
Aging
1
2008
941
0.010
Why?
Neurons
1
2005
484
0.010
Why?
Prognosis
1
2005
1529
0.010
Why?
Child
1
2007
2446
0.010
Why?
Pichardo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (157)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_